Skip to main content
NHI logo

NHI

National Health Investors Inc
$75.84 -0.28 (-0.37%) At close · Jul 15
Market Cap
$3.84B
Shares
48,471,079

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$375.63M +12.1%
FY2025 Revenue FY2008–FY2025
Net Income
$142.18M +3%
FY2025 Net Income FY2008–FY2025
Operating Margin
65.65% +7.6pp
FY2015 Operating Margin FY2008–FY2015
Diluted EPS
$3.02 -3.5%
FY2025 Diluted EPS FY2008–FY2025
Operating Cash Flow
$236.56M +13.9%
FY2025 Operating Cash Flow FY2008–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009 FY2008
$401.46M $375.63M $335.18M $319.84M $278.19M $298.72M $332.81M $318.08M $294.61M $278.66M $248.46M $228.95M $177.51M $117.83M $93.32M $83.74M $82.58M $62.79M $56.94M
$276.24M $268.74M $240.21M
$275.88M $271.6M $257.05M $249.23M $217.7M $271.05M $307.21M $294.18M $280.81M $265.17M $232.35M $214.41M $166.28M $106.03M $81.48M $72.61M $70.92M $53.65M $47.28M
$27.89M $26.87M $20.74M $19.31M $22.77M $18.43M $13.3M $13.4M $12.55M $12.22M $9.77M $10.52M $9.11M $9.25M $7.8M $7.59M $7.79M $5.26M $3.59M
$80.94M $71.44M $69.97M
$0 $0 $1.17M $21.53M $6.4M $6.4M $0 $25K $0 $25K $1.99M
$260.98M $238.96M $211.88M $200.88M $241.86M $216.14M $161.77M $156.81M $139.54M $127.17M $129.69M $102.23M $74.37M $41.83M $25.41M $24.18M $21.07M $14.14M $12.3M
$150.31M $103.05M $79.5M $72.83M $69.82M $61.79M $48.66M $44.64M
65.65% 58.05% 67.47% 78.05% 83.37% 74.82% 77.48% 78.39%
$58.07M $57.37M $59.9M $58.16M $44.92M $50.81M $52.88M $56.3M $49.06M $46.32M $43.11M $37.63M $26.37M $9.23M $3.49M $3.85M $1.55M
$155K $84K $1.24M
$1.39M $596K $566K $269K
$0 $0 $50K $4.58M $1.13M $0 $22.26M $11.97M $3.35M
$3.25M $3.66M $402K $555K $569K -$1.55M -$3.13M $0 $0 $0 -$1.21M -$1.77M -$71K $324K $45K $0 $0
$161.27M $155.07M $151.49M $118.77M $126.72M $103.14M $76M $67.91M $59.56M $61.51M
$138K $124K $854K -$583K $118K $118K $267K $96K $82K
$148.11M $142.18M $137.99M $135.65M $66.4M $111.8M $185.13M $160.46M $154.33M $159.37M $151.54M $148.86M $101.61M $106.18M $90.73M $81.13M $69.42M $64.23M $57.51M
37.85% 41.17% 42.41% 23.87% 37.43% 55.62% 50.45% 52.39% 57.19% 60.99% 65.02% 57.24% 90.12% 97.23% 96.89% 84.07% 102.29% 101%
-$1.39M -$1.39M -$1.35M -$1.27M -$902K $163K $185K -$7000 $0 $0 $1.18M $1.45M $1.44M $999K $167K $0 $0
$147.89M $141.98M $137.87M $135.6M $66.4M $111.8M $0.65
$135.65M $66.4M $118.95M $181.41M $155.73M $156.22M $152.81M $129.36M $170.55M $98.29M $108.17M $91.11M $72.98M $70.65M $67.54M $53.93M
USD/shares $3.03 $3.14 $3.13 $1.48 $2.45 $4.14 $3.70 $3.68 $3.90 $3.88 $3.96 $3.04 $3.74 $3.26 $2.93 $2.51 $2.33 $2.08
USD/shares $4.74 – $4.79 $3.02 $3.13 $3.13 $1.48 $2.44 $4.14G $3.67 $3.67 $3.87 $3.87 $3.95 $3.04 $3.74 $3.26 $2.92 $2.50 $2.32 $2.07
shares 46.87M 43.84M 43.39M 44.77M 45.71M 44.7M 43.42M 41.94M 40.89M 39.01M 37.6M 33.38M 28.36M 27.81M 27.72M 27.66M 27.59M 27.71M
shares 47.05M 44.1M 43.39M 44.79M 45.73M 44.7M 43.7M 42.09M 41.15M 39.16M 37.64M 33.42M 28.4M 27.84M 27.79M 27.73M 27.62M 27.73M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $155.57M in buybacks, $2.33B in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
EV/EBIT
P/E (TTM)
25.53×
REIT - Healthcare Facilities median 33.95×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Real Estate Investment Segment $295,566,000 $280,292,000 $270,675,000 $242,083,000
Senior Housing Operating Portfolio $80,062,000 $54,421,000 $48,809,000 $35,796,000
Key facts CIK 877860 CUSIP 63633D104 13F (30d) 19 filings 18 filers Visit website Investor relations